Improving regenerating potential of the heart after myocardial infarction: factor-based approach
- PMID: 20093126
- DOI: 10.1016/j.lfs.2010.01.004
Improving regenerating potential of the heart after myocardial infarction: factor-based approach
Abstract
The emerging evidence that the heart has the potential to regenerate, albeit not ideally, has stimulated considerable interest in the field of cardiac regenerative medicine. Several lines of research demonstrated that factor-based therapy is feasible and effective, whether it is used independently or as an adjunct to cell therapy. The ultimate goal of the factor-based approach is to improve the regenerating potential of the heart as a means to treat patients with cardiovascular disease. This article reviews recent approaches involving factor-based therapy for cardiac repair and regeneration including some of the advantages of this type of therapy as well as some of the hurdles that must be overcome before this therapeutic approach becomes a standard part of clinical medicine.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study.J Thorac Cardiovasc Surg. 2004 Aug;128(2):245-53. doi: 10.1016/j.jtcvs.2004.04.007. J Thorac Cardiovasc Surg. 2004. PMID: 15282461
-
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S8-13. doi: 10.1038/ncpcardio0409. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16501638 Review.
-
Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction.Cardiol Rev. 2009 Jan-Feb;17(1):1-9. doi: 10.1097/CRD.0b013e31817bd7ab. Cardiol Rev. 2009. PMID: 19092364 Review.
-
[Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S274-9. doi: 10.1055/s-0028-1100961. Epub 2008 Dec 15. Dtsch Med Wochenschr. 2008. PMID: 19085806 Review. German.
-
Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells.J Am Soc Nephrol. 2007 Nov;18(11):2843-52. doi: 10.1681/ASN.2007050597. Epub 2007 Oct 17. J Am Soc Nephrol. 2007. PMID: 17942950 Review.
Cited by
-
Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles.Bioeng Transl Med. 2017 Jun 26;2(2):170-179. doi: 10.1002/btm2.10065. eCollection 2017 Jun. Bioeng Transl Med. 2017. PMID: 28932818 Free PMC article.
-
Sensing the cardiac environment: exploiting cues for regeneration.J Cardiovasc Transl Res. 2011 Oct;4(5):616-30. doi: 10.1007/s12265-011-9299-6. Epub 2011 Jul 7. J Cardiovasc Transl Res. 2011. PMID: 21735303 Free PMC article. Review.
-
Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.J Physiol. 2011 Apr 1;589(Pt 7):1725-40. doi: 10.1113/jphysiol.2010.202366. Epub 2011 Jan 31. J Physiol. 2011. PMID: 21282286 Free PMC article.
-
EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.Cardiovasc Diabetol. 2014 Aug 13;13:114. doi: 10.1186/s12933-014-0114-y. Cardiovasc Diabetol. 2014. PMID: 25166508 Free PMC article.
-
Combination of HGF and IGF-1 promotes connexin 43 expression and improves ventricular arrhythmia after myocardial infarction through activating the MAPK/ERK and MAPK/p38 signaling pathways in a rat model.Cardiovasc Diagn Ther. 2019 Aug;9(4):346-354. doi: 10.21037/cdt.2019.07.12. Cardiovasc Diagn Ther. 2019. PMID: 31555539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical